Vir Biotechnology, Inc. · NASDAQ:VIR

Sawaf Aziz received 75,000 Vir Biotechnology, Inc. shares as an award (Form 4)

Traded Nov 15, 2026 · Filed Nov 16, 2026

On Nov 15, 2026, Sawaf Aziz (EVP, Chief Financial Officer) received 75,000 Vir Biotechnology, Inc. shares as an award under a trading plan, leaving 75,000 shares. Filed Nov 16, 2026 (Form 4).

Awarded
75,000 shares
Holding after
75,000 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP, Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 15, 2026Common StockAward75,00075,000Direct

Source

Download original · View original at SEC

Related